Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 2/3 1

Status

Unknown 2Completed 1

Sponsor Class

OTHER 30NIH 9INDUSTRY 5FED 3OTHER_GOV 1

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 3

Conditions

Prostatic Neoplasms 2Prostate Cancer Diagnosis 1

Interventions

Exercise 6pembrolizumab 5enzalutamide 4Docetaxel 4Colonoscopy 4Celecoxib 4sargramostim 3apalutamide 3Prednisone 3Methods 3Leuprolide 3Itraconazole 3Imiquimod 3Granulocyte-Macrophage Colony-Stimulating Factor 3Golytely 3Cryotherapy 3Abiraterone Acetate 32-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 3abiraterone 2Yoga 2Topotecan 2Testosterone 2Tablets 2Simvastatin 2Radiosurgery 2Palliative Care 2Midazolam 2Gelatin 2Decision Support Techniques 2Collagenases 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
FED × 2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid × Clear all
NCT04390880 2025-05-16

PROSPYL

VA Greater Los Angeles Healthcare System

Phase 2 Completed
239 enrolled 5 charts
Genitourinary

Prostatic Neoplasms

NCT05820724 2023-04-24

PSMA PET Scan and mpMRI for Prostate Cancer Detection

VA Greater Los Angeles Healthcare System

Phase 2 Unknown
100 enrolled
Genitourinary

Prostate Cancer Diagnosis

NCT03852654 2019-02-25

18F-DCFPyL PET-CT Scan and Prostate Cancer

VA Greater Los Angeles Healthcare System

Phase 2/3 Unknown
170 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡